Your impact this year

Everything that has been accomplished is possible thanks to generous supporters like you!

Dr. Ahmad Haidar

McGill University (Montreal, QC)

Dr. Haidar is developing a fully automated, artificial pancreas system (for type 1 diabetes) that continuously monitors a person’s glucose levels and automatically delivers either insulin, pramlintide, or glucagon to regulate & maintain a safe glucose level. No input is needed from the person wearing it, which means no carb counting & no insulin adjustments.

Clinical Practice Guidelines

Helping people with diabetes get the support & resources they need

Based on the latest research & reviewed by healthcare experts, the Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada provides leading-edge medical guidance in diabetes prevention, care & management. Specific recommendations were created for people living with diabetes.

Enhanced Disability Tax Credit

Most people with diabetes face very high medical costs

Diabetes Canada is advocating for a system of enhanced tax credits designed to reduce this burden and addresses the economic reality of living with a chronic condition, regardless of whether or not the condition has actually created a disability. Additional financial support can be a critical factor that makes a difference in quality of life.

Dr. Yuliya Lytvyn

University Health Network (Toronto, ON)

Dr. Lytvyn is investigating a new therapy for kidney damage in people with type 1 diabetes. By combining a drug that lowers blood glucose levels in type 2 diabetes with a drug to treat kidney damage, she hopes to protect the kidneys of people with type 1 diabetes. This could lead to new treatments for those at risk of kidney damage & prevent complications.

Dr. Samaneh Yazdanikivi

Hospital for Sick Children (Toronto, ON)

When the body is in an insulin-resistant state, the delivery of insulin from the blood to tissues is compromised - decreasing insulin access to the tissues. Dr. Yazdanikivi is studying how capillary cells are affected by diabetes. This will determine which therapies improve insulin & glucose delivery to the tissues – leading to new treatments for people with diabetes.

Dr. Thomas Pulinilkunnil

Dalhousie University (Saint John, NB)

Dr. Pulinilkunnil intends to identify, on a cellular level, what causes heart disease in people with diabetes. This research could pave the way for treatments that improve heart function and decrease mortality.

Keep diabetes research moving forward 

When you become a donor, your gift will help researchers conduct their vital research and explore every avenue towards a cure. By giving in this way, you can ensure that research never stops —and that you're part of every new breakthrough.

Donate

Keep diabetes research moving forward

Your donation will ensure research never stops – help End Diabetes Now.

Donate